From: Long-term treatment outcomes with zygomatic implants: a systematic review and meta-analysis
Study | Zygomatic implant number | Success | Failure to meet success | Patient number | Follow-up | Follow-up range |
---|---|---|---|---|---|---|
Pellegrino et al.a 2020 Atrophic Oncologic | 38 35 | 89.8% (CI: 60.4–97.7%) (n = 34) 96.7% (CI:79.2–99.5%) (n = 34) | Mucositis: 13.1% (3.7–41%) Mucositis: 39.7% (9.7–91.7%) Extra-oral swelling (n = 1) | 10 10 | 39.9 |  ± 19.5 |
Davo and Pons 2015 | 68 | 98.5% (n = 67) | Unfavourable position (n = 1) | 14 | 60 | N/A |
Malo et al. 2014 | 92 | 98.8% (n = 91) | PPD > 4 mm (n = 23) | 39 | 60 | N/A |
Davo, Malevez and Pons. 2013 | 69 | 98.55% (n = 68) | NR | 42 | 60 | N/A |
Yates et al. 2013 | 43 | 86.05% (n = 37) | Recession of 2–4 threads (n = 6) | 25 | 72 | 48–72 |
Agliardi et al. 2017 | 42 | 100% (n = 42) | NR | 15 | 85 | 73–91 |
Miglioranca et al. 2012 | 40 | 97.5% (n = 39) | NR | 21 | 96 | Not reported |
Fortin 2017 | 107 | 100% (n = 107) | Successful treatment of infection by implant apicoectomy. (not included in success data by study) | 58 | 100.8 | 60–156 |
Cosola et al. 2021 | 67 | 46.3% (n = 36) | 28 ZI (41.8%) experienced infective complications defined as sinusitis, oro-antral fistula or soft tissue infection. Early neurologic pain following treatment in 8 ZI (11.9%) in 5 patients | 33 | 141.6 | 109–198 |